Want to see TSE:KNE full AI Analyst Report?
Kane Biotech (KNE) Revenue
Kane Biotech Revenue
Kane Biotech had a revenue of 8.14K in the quarter ending Jun 30, 2026, with -81.16%. This bring the company's revenue in the last twelve months to 38.72K, Decreased 33.90%. In the fiscal year ending Mar 31, 2026, Kane Biotech had annual revenue of 427.87K with -79.44% growth.
- Revenue (ttm)
- 38.72K
- Revenue Growth
- ―
- P/S Ratio
- 14.38
- Revenue/Employee
- CAD 13,371
- Employees
- 32
- Market Cap
- CAD 6.15M
Revenue Chart
Kane Biotech Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 427.87K | -1.65M | -79.44% |
| Mar 31, 2025 | 2.08M | 1.93M | 1296.75% |
| Dec 31, 2023 | 148.98K | -7.75K | -4.95% |
| Mar 31, 2023 | 156.73K | -1.45M | -90.25% |
| Dec 31, 2021 | 1.61M | 266.20K | 19.84% |
| Dec 31, 2020 | 1.34M | -351.95K | -20.78% |
| Mar 31, 2020 | 1.69M | 1.19M | 234.51% |
| Dec 31, 2018 | 506.27K | -529.03K | -51.10% |
| Dec 31, 2017 | 1.04M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.